Incidence and treatment of delayed‐onset nodules after VYC filler injections to 2139 patients at a single Canadian clinic

BACKGROUND: Data suggest that hyaluronic acid (HA) fillers using VYC technology have a higher incidence of delayed‐onset nodule development at facial injection sites than earlier HA products. OBJECTIVE: To assess the incidence of delayed‐onset nodules with VYC products based on a single experienced...

Descripción completa

Detalles Bibliográficos
Autor principal: Rivers, Jason K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Injectable Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321104/
https://www.ncbi.nlm.nih.gov/pubmed/35451214
http://dx.doi.org/10.1111/jocd.15013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321104/
https://www.ncbi.nlm.nih.gov/pubmed/35451214
http://dx.doi.org/10.1111/jocd.15013

Ejemplares similares